Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 27 Apr 23 424B3 Prospectus supplement
- 25 Apr 23 424B4 Prospectus supplement with pricing info
- 25 Apr 23 EFFECT Notice of effectiveness
-
21 Apr 23 S-1/A IPO registration (amended)
- 20 Apr 23 FWP Free writing prospectus
- 20 Apr 23 S-1/A IPO registration (amended)
- 18 Apr 23 FWP Free writing prospectus
- 11 Apr 23 FWP Free writing prospectus
- 6 Apr 23 FWP Free writing prospectus
- 4 Apr 23 S-1/A IPO registration (amended)
- 13 Feb 23 FWP Free writing prospectus
- 6 Feb 23 S-1 IPO registration
MAIA similar filings
Filing view
External links
Exhibit 23.3
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated March 24, 2023, with respect to the consolidated financial statements of MAIA Biotechnology, Inc. contained in the Registration Statement and Prospectus. We consent to the use of the aforementioned report in the Registration Statement and Prospectus, and to the use of our name as it appears under the caption “Experts.”
/s/ GRANT THORNTON LLP
Charlotte, North Carolina
April 21, 2023